These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28692863)

  • 1. Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India.
    Kaur G; Gupta D; Chavan BS; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J
    Asian J Psychiatr; 2017 Oct; 29():174-182. PubMed ID: 28692863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.
    Alladi CG; RajKumar RP; Adithan S; Marie-Claire C; Bellivier F; Shewade DG
    Fundam Clin Pharmacol; 2019 Jun; 33(3):355-364. PubMed ID: 30332506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of maintenance therapy of Risperidone with CYP2D6 genetic polymorphisms through an extended translational framework-based prediction of target occupancies/clinical outcomes.
    Li HQ; Xu JY; Gao YY; Jin L
    Pharmacol Res; 2018 Nov; 137():135-147. PubMed ID: 30281999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
    J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.
    Lane HY; Lee CC; Chang YC; Lu CT; Huang CH; Chang WH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):461-70. PubMed ID: 15140279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
    Yamanouchi Y; Iwata N; Suzuki T; Kitajima T; Ikeda M; Ozaki N
    Pharmacogenomics J; 2003; 3(6):356-61. PubMed ID: 14610521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.
    Ma L; Zhang X; Xiang Q; Zhou S; Zhao N; Xie Q; Zhao X; Zhou Y; Cui Y
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):94-104. PubMed ID: 30103286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics.
    Lane HY; Lee CC; Liu YC; Chang WH
    Pharmacogenomics; 2005 Mar; 6(2):139-49. PubMed ID: 15882132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders.
    Sukasem C; Hongkaew Y; Ngamsamut N; Puangpetch A; Vanwong N; Chamnanphon M; Chamkrachchangpada B; Sinrachatanant A; Limsila P
    J Clin Psychopharmacol; 2016 Apr; 36(2):141-6. PubMed ID: 26872113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
    Kurylev AA; Brodyansky VM; Andreev BV; Kibitov AO; Limankin OV; Mosolov SN
    Psychiatr Danub; 2018 Jun; 30(2):157-163. PubMed ID: 29930225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.
    Charan A; Shewade DG; Rajkumar RP; Chandrasekaran A
    Psychiatry Res; 2016 Jun; 240():209-213. PubMed ID: 27111215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone.
    Ganoci L; Trkulja V; Živković M; Božina T; Šagud M; Lovrić M; Božina N
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110042. PubMed ID: 32682874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
    Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A
    Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone plasma levels, clinical response and side-effects.
    Riedel M; Schwarz MJ; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.
    Reynolds GP; Yao Z; Zhang X; Sun J; Zhang Z
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):143-51. PubMed ID: 15695058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.
    Xing Q; Qian X; Li H; Wong S; Wu S; Feng G; Duan S; Xu M; Gao R; Qin W; Gao J; Meng J; He L
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):631-7. PubMed ID: 17105675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
    Roke Y; van Harten PN; Franke B; Galesloot TE; Boot AM; Buitelaar JK
    Pharmacogenet Genomics; 2013 Sep; 23(9):487-93. PubMed ID: 23851570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients.
    Maffioletti E; Valsecchi P; Minelli A; Magri C; Bonvicini C; Barlati S; Sacchetti E; Vita A; Gennarelli M
    Drug Dev Res; 2020 Sep; 81(6):754-761. PubMed ID: 32462699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia.
    Zeng L; Kang C; Yuan J; Zhang Y; Wei Y; Xu L; Zhou F; Yang J
    Schizophr Res; 2017 Oct; 188():50-51. PubMed ID: 28131599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.